Coveo, a leading provider of Enterprise Search 2.0 and Customer Information Solutions, today announced it has expanded its executive team with the addition of Ed Shepherdson as managing director, Customer Information Solutions. In this role, Shepherdson is responsible for leading Coveo's Customer Information Solutions line of business including strategy, solutions development, services, marketing and sales.
(Photo: http://photos.prnewswire.com/prnh/20110110/NY26944 )
(Logo: http://photos.prnewswire.com/prnh/20100421/NY90043LOGO )
Shepherdson brings 30 years of experience in the technology industry to his role with Coveo. Most recently he was vice president of ... read more
SAN FRANCISCO, CA -- (Marketwire) -- 01/10/11 -- The Linux Foundation, the nonprofit organization dedicated to accelerating the growth of Linux, today announced that Broadcom Corporation is its newest member.
In September, Broadcom® announced it had open sourced its drivers for selected Wi-Fi chipsets, a pivotal move that garnered applause throughout the Linux community. Since then, the driver has been integrated into the latest Linux kernel release 2.6.37 and, as a result, is actively being improved upon by the ... read more
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced unaudited
total net revenues for both the fourth quarter and full year ended
December 31, 2010.
Following is a table detailing 2010 full year and fourth quarter
... read more
Ultimate Software (Nasdaq: ULTI), a leading provider of unified,
end-to-end human capital management (HCM) SaaS solutions for global
businesses, will be hosting a conference call on Tuesday, February 8 at
5:00 p.m. Eastern time to discuss its financial results for the fourth
quarter and year-end of ... read more
Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the receipt of a European patent for a PyroCarbon humeral head design currently being developed as a component of the TITAN(TM) Modular Shoulder System released in September 2010.
Jerome Klawitter, Ph.D., Founder and Chief Science Officer of Ascension Orthopedics, commented, "I am very pleased our PyroCarbon humeral head hemi-arthroplasty has been patented. PyroCarbon has been shown to cause much less damage to cartilage and bone joint tissues than the ... read more
Sequenom (Nasdaq: SQNM) today announced the appointment of William (Bill) Welch to the position of senior vice president of diagnostics.
Mr. Welch will report to Harry F. Hixson, Jr., Ph.D. chairman and CEO of Sequenom, and he will be responsible for all commercial aspects of the company's diagnostics business.
"Bill has an outstanding track record of success in medical device and biopharmaceuticals sales and marketing leadership," said Harry F. Hixson, Jr., Ph.D., chairman and chief executive officer. "His proven ... read more
ForeSee Results today released new research showing that consumers are using mobile phones more than ever for retail purposes.
As part of a study of nearly 10,000 visitors to the biggest e-retail websites in the United States (determined by revenue, according to Internet Retailer), customer experience analytics firm ForeSee Results used the methodology of the American Customer Satisfaction Index (ACSI) to examine how mobile shopping trends during the holiday season could have year-long implications. The ACSI is able to show ... read more
Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of consulting firm Booz Allen Hamilton Inc., announced today its intention to refinance $1,021.5 million of indebtedness outstanding under its senior secured credit facilities and $222.1 million of indebtedness outstanding under its mezzanine credit facility. Funds for refinancing the existing credit facilities will come from cash on hand as well as from new secured debt expected to be raised under its senior secured credit facilities. After completion of the proposed ... read more
Kovarus, Inc., a premier technology consulting firm specializing in data center design, implementation, and optimization, today announced it has joined the Vblock(TM) partner ecosystem, a community of partners that are qualified to augment, resell, and deliver VCE's Vblock Infrastructure Platform. These packages are an element of VCE, the Virtual Computing Environment, formed by Cisco and EMC with investments from VMware and Intel. Now Kovarus can help customers accelerate their adoption of converged infrastructure and cloud-based computing models to dramatically reduce ... read more
ARRL, the national association for Amateur Radio has filed a complaint with the Federal Communications Commission documenting ongoing harmful interference and egregious rules violations by Broadband over Power Lines (BPL) systems installed by IBEC, Inc. in Virginia, Pennsylvania, and Indiana. The ARRL has requested that the FCC "initiate immediately an enforcement proceeding regarding these BPL systems, and cause them to cease operation until such time as they are each in full compliance with the Commission's Rules."
Contrary to earlier representations to ... read more
Do you know an everyday hero who is making great strides today to ensure a greener tomorrow? Cox Communications, in partnership with The Trust for Public Land (TPL), today launched Virginia's Cox Conserves Heroes program, a national awards program to honor and celebrate conservation in everyday life.
(Logo: http://photos.prnewswire.com/prnh/20070925/CLTU013LOGO-a )
Sponsored in Virginia by Casey Auto Group, Cox Conserves Heroes honors individuals who are helping to create, preserve or enhance outdoor places for everyone to enjoy. Eligible work must be done ... read more
Carousel Industries, a leader in data networking, infrastructure and converged communications announced today that it has acquired TAC Centre, a leading provider of Nortel communications solutions headquartered in Westwood, MA. The acquisition brings a strong base of Nortel customers into the Carousel fold, including a high concentration of healthcare and higher education customers across the nation. The acquisition also brings a number of senior engineers; all certified on a variety of technologies including Nortel, Microsoft, Cisco, and Adtran. ... read more
Hughes Network Systems, LLC (HUGHES), the global leader in broadband satellite networks and services, and a leading provider of managed network and application services, today launched its managed Voice-over-IP (VoIP) solution for the distributed enterprise. Using the new Hughes ActiveQoS(TM) technology, Hughes can provide superior voice quality over affordable broadband, eliminating the need for customers to invest in expensive leased line MPLS networks.
ActiveQoS Ensures High Quality Voice
Hughes ActiveQoS technology is integrated into the Hughes customer premise equipment and ... read more
Ltd. (TASE: NSVX), a leading company in the development of improved vaccine
and immunotherapeutics, announced today that Dr. Rom Eliaz, CEO, will
participate in the J.P. Morgan 29th Annual Healthcare Conference and will
present at the Biotech Showcase, at 9:30 am PST/12:30 noon EST on January 12,
2011. Dr. Eliaz will present a corporate overview on NasVax and also will
join some of the world's leading infectious disease companies in the CEO
panel entitled "Infectious Disease: A War on Many Fronts - Can it be won?" ... read more
Genomic Health, Inc. (Nasdaq: GHDX) today announced it will accelerate its prostate cancer clinical development program with the goal of launching a test globally in 2013, previously planned for launch in 2014, in light of positive top-line results of a large gene identification study which were presented in December at the Society for Urologic Oncology (SUO) annual meeting. Genomic Health and its research partners from Cleveland Clinic plan to present complete data at the ASCO Genitourinary Cancer Symposium and ... read more
CareCentrix, Inc., the nation's leading provider of home health benefits management services, announced today that Rex Adams will join the executive team reporting to Eric Reimer, chief executive officer. Adams will serve as chief operations officer, with oversight of core operations, including information technology, claims management and all regional customer centers.
Previously the chief operating officer for WellCare Health Plans, Inc. (NYSE: WCG), Adams had full responsibility for all operations, data and technology activities at the company. He played ... read more
Cephalon, Inc. (Nasdaq: CEPH) and Mesoblast Limited (ASX: MSB; Pink Sheets: MBLTY) today announced positive interim results from Mesoblast's ongoing multi-center Phase 2 trial of its "off-the-shelf" proprietary adult stem cell product Revascor(TM) for patients with congestive heart failure. Patients who received a single injection of Revascor(TM) into damaged heart muscle have had less cardiac events, deaths, and hospitalizations during the follow-up period to date than control patients.
Cephalon and Mesoblast have entered into a strategic alliance to develop ... read more
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the J.P. Morgan 29th Annual Health Care Conference on Wednesday, January 12, 2011 at 10:30 a.m. PT. The conference will be held at the Westin St. Francis in San Francisco, Calif.
A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events ... read more
Mpex Pharmaceuticals, Inc. today during the JP Morgan 29th Annual Healthcare Conference, announced that it has initiated its Phase 3 clinical trial program with Aeroquin(TM) (MP-376) for the treatment of pulmonary infections in patients with cystic fibrosis (CF). Aeroquin is Mpex's proprietary aerosol formulation of levofloxacin, an antibiotic that has potent activity against key bacterial pathogens in CF including Pseudomonas aeruginosa.
The first study in this program is a multi-center, international, randomized, double-blind, placebo-controlled trial (Mpex 207) that is expected to ... read more
Excaliard Pharmaceuticals, Inc., today announced results from three Phase 2 clinical trials of EXC 001 in skin scarring. EXC 001 is an antisense oligonucleotide designed to interrupt the process of fibrosis by inhibiting expression of connective tissue growth factor (CTGF). The three studies demonstrated EXC 001's efficacy in elective revision surgery of scars resulting from prior breast surgery (Study 203), efficacy in fine line scars in elective abdominoplasty surgery (Study 202) and activity in a biomarker study of abdominal scars ... read more